« Back
Home /
EBV EBNA-3A 325-333 (HLA-B*08:01)

EBV EBNA-3A 325-333 (HLA-B*08:01)

€115.00

Excl. VAT

Item no.	EP06163_5
Manufacturer	peptides & elephants
Amount	5 mg
Category	Peptides & Proteins Peptides
Type	Peptides
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	FLRGRAYGL Epstein-Barr nuclear antigen HLA-B*08:01 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Available
Description	Antigen Peptide EBV EBNA3A HLA-B08:01 (FLRGRAYGL) for stimulation of human EBV EBNA-3A(325-333) -specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B0801 allele.
Keywords	FLRGRAYGL Epstein-Barr nuclear antigen HLA-B*08:01 Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Sequence	FLRGRAYGL
N-Terminus	H
C-Terminus	OH
Purity	0, 95
Counter-Ion	TFA
Protein	Epstein-Barr nuclear antigen
Gene	EBNA
Allele	HLA-B*08:01
Application	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication	Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma
Storage	Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

Listprice: €115.00

Price: €115.00

available

Delivery expected until 9/18/2025

Quantity:

Compare